All In MedTech

Device Trial Radar · NCT03320096

Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis

Last checked: Nov 20, 2026Latest source record: Jul 10, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

20

Actual

Start

Dec 13, 2016

Primary completion

Jun 19, 2017

Study completion Aug 22, 2017

Sponsor

Lead sponsor
Ulthera, IncNot on our public-company list
Sponsor type
Industry
First posted
Oct 25, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the Ulthera System and the 7-3.0mm transducer for treating axillary hyperhidrosis.

Conditions

  • Axillary Hyperhidrosis

Interventions

  • Microfocused ultrasound with visualizationDevice

    Subjects will receive 2 treatments (day 1 and day 30), each at a 3.0mm depth and 0.30 Joule of energy. Treatment will be delivered in a 3\*4 grid, 12 treatment squares, delivering 60 lines of treatment per square, i.e., 720 lines per axilla in each treatment (1440 lines total per treatment.)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Hyperhidrosis Disease Severity Scale (HDSS) Score Reduction at Day 30 Post Second TreatmentTime frame: Day 60 (30 days post second treatment)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Rosenpark Research, Study Research Center; Merz Investigational Site #0490099

    Darmstadt, Germany

  • Haut- & Laserzentrum, Merz Investigational Site #0490362

    Potsdam, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.